A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038)
Clinical trial NCT03696108 · COMPLETED
Trial details
- NCT number
- NCT03696108
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-31
- Primary completion
- 2020-10-07
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.